About me
Pete Schaeffer has worked in the Pharmaceutical industry for approximately 20 years in both the Pre-Clinical and Clinical areas. During this time, he has worked in roles to improve performance and decision making, led continuous improvement programs and collaborated with teams to drive new ways of working. In his current role of Analytics Director in Third-Party Risk and Oversight at GlaxoSmithKline, Pete is focused on implementing both new ways of working and tools to improve supplier oversight for R&D programs. He also leads the Patient Technology (PT) Tools workstream for TransCelerate aiming to implement PT at scale. The PT workstream aligns with his passion of improving patient experience and accelerating clinical trials.
